Insulin Types: What Every Patient Needs to Know About Rapid, Long-Acting and Premixed

Why do so many different insulin types exist?

A healthy pancreas secretes insulin in two distinct patterns: a low, constant background level throughout the day that prevents blood glucose from rising between meals, and a sharp, fast burst at mealtimes to handle the glucose arriving from food. In type 1 diabetes both patterns are lost entirely. In type 2 diabetes one or both may need to be supplemented as the condition progresses.

Different insulin formulations were developed to mimic these natural patterns as closely as possible. Rapid-acting and short-acting insulins replicate the mealtime burst; long-acting insulins replicate the steady background; premixed insulins attempt to cover both in a single injection.

Understanding the difference is not academic. A person who injects rapid-acting insulin at the wrong time relative to a meal, or who expects long-acting insulin to behave like rapid-acting, will experience unexplained swings in glucose that are hard to manage and harder to explain to a doctor.

Insulin types: onset, peak and duration

Rapid-acting insulins such as lispro, aspart and glulisine begin working within 10 to 20 minutes, reach their peak effect after 1 to 2 hours, and last 3 to 5 hours. They are usually injected 10 to 15 minutes before a meal, or at the start of eating. If you delay a meal after injecting, or eat substantially less than planned, you are at risk of hypoglycaemia.

Regular or short-acting insulin is an older formulation that begins working after 30 to 60 minutes, peaks at 2 to 4 hours, and lasts 6 to 8 hours. This is why it must be taken 30 minutes before a meal, not immediately before eating as with rapid-acting. Mixing up the timing of these two types is one of the most common errors patients make.

Intermediate-acting insulin (NPH) begins working after around 2 hours, peaks between 4 and 12 hours, and lasts 12 to 18 hours. Long-acting insulins such as glargine, detemir and degludec begin slowly, have no pronounced peak, and last 20 to 42 hours depending on the specific formulation. They are given once or twice daily to provide a stable background level.

Premixed insulin: who is it right for?

Premixed insulins combine a fixed proportion of rapid-acting or short-acting insulin with intermediate-acting insulin in one pen or vial. The numbers in the product name indicate the ratio: a 70/30 formulation contains 70 percent intermediate and 30 percent rapid. This is convenient because it requires fewer injections and less calculation at each meal.

Premixed insulin suits people with a regular lifestyle, consistent meal sizes, and predictable mealtimes. It is less flexible for those whose diet and schedule vary significantly from day to day, because the ratio cannot be adjusted for individual meals without changing the total dose.

The fundamental limitation of premixed insulin is that both components are locked together. Adjusting one means adjusting the other. Many endocrinologists eventually prefer to move to separate basal and bolus insulins, which allow each component to be titrated independently. This is nearly universal in type 1 diabetes management.

Injection technique and site rotation

Approved injection sites are the abdomen on both sides of the navel (keeping at least 5 cm from the navel itself), the front and outer thigh, the outer upper arm, and the upper outer buttock. Absorption speed differs between sites: the abdomen absorbs fastest, the thigh and buttock slowest. Many clinicians advise using the same region for the same type of insulin each day, to keep absorption behaviour predictable.

Rotating within that region is essential. A 2022 study published in the Journal of Diabetes Investigation confirmed that repeated injections into the same small spot cause fatty tissue to accumulate under the skin in a process called lipohypertrophy. This buildup can be felt as a rubbery lump. Insulin injected into a lipohypertrophic site is absorbed erratically, which explains why glucose can swing unpredictably even when the dose and the meal look identical.

For the injection itself: draw up or dial the correct dose, pinch a small fold of skin if fat tissue is thin, insert the needle at 90 degrees for most adults, press the plunger slowly, and wait 10 seconds before withdrawing the needle. This pause prevents medicine from leaking back along the needle track.

Hypoglycaemia: what it is and how to act

Hypoglycaemia (low blood glucose) is the most immediately dangerous risk in the day of a person using insulin. It happens when there is more insulin active in the blood than the available glucose can offset, whether because a meal was smaller than usual, physical activity was greater than expected, or a meal was delayed after an injection.

Early warning signs include: trembling or shaking, sudden sweating, pallor, intense hunger, a racing heartbeat, and difficulty concentrating. When you notice these signs and suspect your glucose is low, act immediately. Consume 15 grams of fast-acting carbohydrate, such as half a glass of fruit juice, a small carton of milk, or a few glucose tablets. Recheck your glucose after 15 minutes and repeat if still low.

Researchers writing in Nature Reviews Endocrinology documented that severe, untreated hypoglycaemia can progress to loss of consciousness and seizures. If a person loses consciousness, never try to give them food or drink by mouth because this is dangerous. Turn them onto their side, administer a glucagon kit if one is available, and call emergency services immediately.

Storing insulin in hot climates

This is a genuine and underaddressed problem across the Arab world. Unopened insulin should be stored in a refrigerator between 2 and 8 degrees Celsius and must never be frozen. An opened pen or vial that you are actively using typically remains stable at room temperature for 28 days, according to most manufacturers' instructions.

A 2021 study published in PloS One tested several insulin types at temperatures above 37 degrees Celsius and found accelerated degradation, particularly in long-acting analogues such as glargine. In Arab summers where temperatures regularly exceed 40 degrees, leaving insulin in a car, near a window or in an unventilated room can damage it within hours. Degraded insulin often shows no visible change in colour or clarity, which makes it particularly deceptive.

During power cuts, which affect parts of Iraq, Syria and Lebanon frequently, store insulin in a cool, dark container with crushed ice that does not touch the vial directly. Research published in Tropical Doctor documented that unglazed clay pots kept damp provide genuine cooling through evaporation and can protect temperature-sensitive medicines in the absence of refrigeration. Never freeze insulin and never expose it to direct sunlight.

Daily life with insulin

Physical exercise lowers blood glucose and increases the cells' sensitivity to insulin, which is a long-term benefit but a short-term challenge requiring adjustment. Measure your glucose before and after activity. Discuss with your doctor whether you need to reduce your rapid-acting insulin before exercise, eat a small snack beforehand, or both. Intense exercise can also cause delayed hypoglycaemia several hours after finishing, so checking glucose before bed after an active day is worthwhile.

Illness and fever raise blood glucose despite reduced food intake, because the liver releases stored glucose as part of the stress response. Do not stop insulin during illness even if you are eating very little. Work out a sick-day plan with your doctor or diabetes nurse in advance, so you know exactly what to do before you need it. Patients who stop insulin when ill because they are not eating account for a significant proportion of diabetic ketoacidosis admissions.

Long-distance travel and crossing time zones requires advance planning for long-acting insulin timing. Always carry insulin in hand luggage rather than checked baggage, which may experience extreme temperature swings in the hold. Bring a medical letter confirming your diagnosis and the need to carry needles through security checkpoints.

Telling people around you that you use insulin is not weakness; it is self-protection. If you experience a sudden episode of hypoglycaemia at work or in a public place, having someone nearby who knows what you carry and how to help can be life-saving. Teach family members and close colleagues the signs of low glucose and how to give you fast sugar or to use a glucagon kit if one is available.

When does the dose need to change?

The dose that works well today may need revision when your circumstances change. Weight gain typically increases insulin requirement. Weight loss or increased physical activity may improve insulin sensitivity, allowing better control on a lower dose. The body's needs can also shift seasonally, as people tend to be more active in cooler months.

Any glucose pattern that repeats over two or more days is worth discussing with your doctor or diabetes nurse. Do not adjust the dose after a single unexplained result. Instead, log your meals, injection times and glucose readings over a few days so that a pattern becomes visible. A clear log is far more useful in a clinic appointment than a recalled impression.

Some people with newly diagnosed type 1 diabetes experience a honeymoon phase in the first months, during which the remaining beta cells continue producing some insulin. During this period insulin requirements drop noticeably, then rise again as the remaining cells are lost. A review published in JAMA in 2026 described this phase as common but variable in duration. Recognising it prevents unnecessary dose reductions that will need to be reversed later.

Sources

• Frid AH, Kreugel G, Grassi G et al: New Insulin Delivery Recommendations, Mayo Clinic proceedings, 2016
• Kaufmann B, Boulle P, Berthou F et al: Heat-stability study of various insulin types in tropical temperature conditions: New insights towards improving diabetes care, PloS one, 2021
• Murao S, Murao K, Nagata T et al: Repeated insulin injection without site rotation affects skin thickness - ultrasonographic and histological evaluation, Journal of diabetes investigation, 2022
• Umpierrez G, Korytkowski M: Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia, Nature reviews. Endocrinology, 2016
• Bochanen N, Decochez K, Heleu E et al: Lipohypertrophy Monitoring Study (LIMO): Effect of single use of 4 mm pen needles combined with education on injection site rotation on glycaemic control, Diabetic medicine, 2022
• Jacobsen LM, Schatz DA: Type 1 Diabetes: A Review, JAMA, 2026
• Gill G, Price C, English P et al: Traditional clay pots as storage containers for insulin in hot climates, Tropical doctor, 2002